Alyssa Farrell serves as Senior Director of Product Marketing at SAS, leading platform and horizontal solutions marketing as well as the company’s Launch Program Office. Known for aligning technology innovation with shifting market demands, Alyssa shapes marketing strategies that bring together thought leadership, high-impact content, and go-to-market execution across SAS’s data and AI portfolio—helping organizations turn analytics into competitive advantage. Prior to joining SAS, Alyssa was a senior consultant in the Deloitte Public Sector practice. She earned her MBA from the University of Arizona and holds a Bachelor of Arts from Duke University. Follow Alyssa on Twitter @alyssa_farrell and LinkedIn at http://LinkedIn.com/in/alyssafarrell
The health care industry has more data than it can utilize in meaningful decision-support capabilities. Whether it is the volume, the velocity, or the variety of the data, wrangling insights from this incessant stream is a never-ending and complex task. Enter the age of AI, where an agent can synthesize
Another promise of innovation and advancement? Not in 2025. The hype of market disruption and transformation might be the content that catches attention, but it’s not always the most accurate description of the industry. For far too long, industry experts have praised the ideas of future-forward growth and promised year-over-year
Inequities in cancer care cause specific populations in the U.S. and worldwide to bear a more significant burden of disease than the general population, based upon barriers. These barriers to prevention and care have long existed but were undeniably exacerbated by the COVID-19 pandemic. February 4 marks World Cancer Day, which
